On Invalid Date, Rockwell Medical (NASDAQ: RMTI) reported Q3 2022 earnings per share (EPS) of -$0.40, up 55.06% year over year. Total Rockwell Medical earnings for the quarter were -$4.19 million. In the same quarter last year, Rockwell Medical's earnings per share (EPS) was -$0.89.
On Invalid Date, Rockwell Medical (NASDAQ: RMTI) reported Q3 2022 revenue of $18.69 million up 16.91% year over year. In the same quarter last year, Rockwell Medical's revenue was $15.99 million.
What was RMTI's revenue growth in the past year?
As of Q1 2023, Rockwell Medical's revenue has grown 11.44% year over year. This is 214.84 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 226.28%. Rockwell Medical's revenue in the past year totalled $68.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.